Stay updated on MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.

Latest updates to the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays a 403 Forbidden error in place of the study details, with the addition of standard page chrome such as a 403 header and a Home link in the navigation/footer.SummaryDifference25%

- Check35 days agoChange DetectedThe page now includes additional NIH grant/contract entries for 2019 and 2023, signaling updated funding information for the study; a new Revision tag shows Revision: v3.6.6, replacing the prior v3.6.5.SummaryDifference0.1%

- Check50 days agoChange DetectedPlain Language Summary section removed from the study page, removing a lay-friendly overview of the trial. All other study details remain available on the page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page revision label updated from v3.6.4 to v3.6.5, indicating a small update to the page without substantive changes to the study information.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page shows an updated revision from v3.6.3 to v3.6.4, indicating a minor site update with no visible changes to the study content or user-facing features.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a newer software version was deployed. This is a backend update rather than a modification to trial information.SummaryDifference0.0%

Stay in the know with updates to MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.